Will Computerization Drive a Convergence of Pathology and Radiology?

Will Computerization Drive a Convergence of Pathology and Radiology?

It is tough to give the last talk on the future with so many excellent presentations. Let me give you a little bit different sense of what may be defining future developments in the practice of pathology. Obviously, Siemens (Malvern, Pa) and General Electric (Fairfield, Conn) were invited to speak today because collectively we have recently spent, between the General Electric purchase of Amersham and our purchases of Diagnostics Products Corporation, Bayer Diagnostics, and Dade Behring, $20 billion in this space (prepared August 1, 2007 with Siemens planned acquisition of Dade Behring announced). Why are we investing in in vitro diagnostics? There have been discussions about whether pathology is merging into radiology or radiology merging into pathology. I think the drivers are probably not that but, in part, some basic world views. First, it appears that there are reasonable returns on capital in diagnostics, compared with other worldwide investment opportunities. There is obviously the aging of the population. There are the advances in science, and then finally, there is a “hedging your bet” strategy, because at the end of the day, both imaging and laboratory diagnostic strategies compete in the same space. To the extent that you have more of the diagnostic waterfront covered, you have a better shot at having the diagnostic tools that actually make the diagnoses.

Will Computerization Drive a Convergence of Pathology and Radiology?

Will Computerization Drive a Convergence of Pathology and Radiology? | | 4.5